Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1993-1-6
pubmed:abstractText
The effects of naloxone on the analgesic response were examined using the tail-flick test, in mice with streptozotocin-induced diabetes. Subcutaneous injection of naloxone (5 mg/kg, s.c.) produced a marked analgesia in diabetic mice but not in age-matched non-diabetic mice. Naloxone-induced analgesia in diabetic mice was significantly reduced by pretreatment with naltrindole (0.1 mg/kg, s.c.), a selective antagonist of delta-opioid receptors. By contrast, no significant naloxone-induced increase in tail-flick latency in diabetic mice was observed after chronic treatment with naloxone (5 mg/kg, s.c.) for 5 days. However, the tail-flick latency was significantly increased by chronic treatment with naloxone in non-diabetic mice. Furthermore, the significant naloxone-induced increase in tail-flick latency in non-diabetic mice that had been chronically treated with naloxone was also antagonized by pretreatment with naltrindole. Chronic pretreatment with 5 mg/kg of naloxone for 5 days markedly attenuated the analgesic effect of the delta-agonist DPDPE in diabetic mice, whereas this pretreatment significantly enhanced the effect of DPDPE in non-diabetic mice. These results suggest that naloxone-induced 'paradoxical' analgesia in mice may be mediated predominantly by delta-opioid receptors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0006-8993
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
592
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
101-5
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:1450902-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benz..., pubmed-meshheading:1450902-Analgesia, pubmed-meshheading:1450902-Animals, pubmed-meshheading:1450902-Diabetes Mellitus, Experimental, pubmed-meshheading:1450902-Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, pubmed-meshheading:1450902-Enkephalin, D-Penicillamine (2,5)-, pubmed-meshheading:1450902-Enkephalins, pubmed-meshheading:1450902-Hot Temperature, pubmed-meshheading:1450902-Injections, Intraventricular, pubmed-meshheading:1450902-Male, pubmed-meshheading:1450902-Mice, pubmed-meshheading:1450902-Mice, Inbred ICR, pubmed-meshheading:1450902-Naloxone, pubmed-meshheading:1450902-Pain, pubmed-meshheading:1450902-Pain Measurement, pubmed-meshheading:1450902-Pyrrolidines, pubmed-meshheading:1450902-Reaction Time, pubmed-meshheading:1450902-Time Factors
pubmed:year
1992
pubmed:articleTitle
Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors.
pubmed:affiliation
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hoshi University, Tokyo, Japan.
pubmed:publicationType
Journal Article